124I-AT03
- Generic Name
- 124I-AT03
A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2022-09-15
- Lead Sponsor
- Attralus, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT05201911
- Locations
- 🇺🇸
University of Tennessee Medical Center, Knoxville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath